Martes 12 de Diciembre 2017

Introducing Tylactin Complete Bars for Tyrosinemia (TYR)

Guía de Regalos

AYER, Mass.–(BUSINESS WIRE)–#TYR–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for
inborn errors of metabolism and ketogenic diet therapy, announces the
launch of Tylactin™ COMPLETE Bars, a nutritionally complete
medical food, available in a convenient portable format, for the dietary
management of Tyrosinemia (TYR).


Tylactin with GMP is made from a natural whole protein derived from whey
called glycomacropeptide (GMP). Cambrooke Therapeutics was the first
company to provide individuals with Tyrosinemia natural whole protein
medical foods—Tylactin RTD and Tylactin RESTORE. Now, Tylactin
COMPLETE Bars
provides an additional option for individuals
struggling to consume their formula or those people who need a compact,
on-the-go, and great-tasting formula.

Each Tylactin COMPLETE Bar package contains three segments, each
with 5g protein equivalents. This novel bar format is available in a
delicious chocolate/peanut butter flavor. Tylactin COMPLETE Bars
are an ideal addition to any TYR diet program for use at school, as a
snack, or any time on-the-go convenience is desired.

“My son struggled to take all his formula every day,” says Maria C.,
mother to a TYR child. “He does not want to finish it, and I have had to
watch him carefully. This new Tylactin COMPLETE Bar is a joy for
him, and I never have to worry about him finishing it. I am so thankful
to Cambrooke for inventing such a wonderful product for my son.”

About Cambrooke Therapeutics – Founded in 2000, Cambrooke
Therapeutics is a private equity-backed, Massachusetts-based therapeutic
nutrition company and global provider of medical nutrition products for
patients with serious unmet medical needs. The company works with
physicians and researchers from around the world to develop, test and
commercialize products that are focused on inborn errors of metabolism
and intractable epilepsy. More information is available at www.cambrooke.com.

Contacts

Cambrooke Therapeutics Inc.
Elayna Rucker-Byers, 301-980-6594
erucker-byers@cambrooke.com